.jpg)
Search
- 3 days ago
- 3 min
Lixte Biotechnology (Nasdaq: LIXT) resumes enrollment for its trial for recurrent, malignant tumors
THE study is designed to determine the extent to which LB-100 enters recurrent GBMs and related brain tumors.
- 7 days ago
- 3 min
Healint and Nestle Health Science Partners initate a virtual study on ketogenic migraine treatment
Migraine is the sixth most disabling illness in the world, which affects around a billion people worldwide.
- Nov 19
- 3 min
Alpheus Medical raises $16 million for human trials of therapy for solid body cancers
The company's lead product utilizes a novel, non-invasive drug-device combination for outpatient treatment of rGBM.
- Nov 6
- 3 min
Preclinical Parthenon Therapeutics closes on $65 million to advance anti-cancer therapeutics
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).
- Oct 14
- 3 min
Contract Research Organization Sai Life Sciences expands capabilities and funding
Sai Life Sciences is a CRO-CDMO that enables pharma and biotech companies to accelerate the discovery and development of small molecules.
- Sep 28
- 2 min
Korea's CGBIO and NDR Medical Technology to collaborate on AI and medical imaging for surgeons
By providing reliable and accurate medical services to patients, CGBIO counts on stronger business competitiveness in digital healthcare.
- Sep 10
- 3 min
HTL Biotechnology becomes the exclusive API manufacturer for Eirion Therapeutics
This agreement marks an expansion of HTL's biotechnology beyond its work in hyaluronic acid and bio-polymer manufacturing.
- Sep 3
- 2 min
Cellect Biotechnology (Nasdaq: APOP) announces its first US ApoGraft Bone Marrow Transplantation
Cellect Biotechnology has developed a breakthrough technology, for the selection of stem cells from any given tissue.
- Aug 18
- 5 min
EpiEndo Pharmaceuticals closes on $23.4 million to advance its non-antibiotic macrolide for COPD
The financing secures funds to advance clinical development of EpiEndo’s lead compound EP395, which entered phase I clinical trials in April
- Jul 26
- 3 min
83bar receives investment to further involvement in clinical trials sector and medical marketing
Data collected on the platform has resulted in a proprietary database of over one million patients that can be specifically targeted...
- Jul 21
- 3 min
Nanopharm and Leyden Labs to jointly develop intranasal spray for respiratory viruses
“Leyden Labs is taking a really exciting approach to finding solutions for the broad-spectrum prophylactic protection against..."
- Jul 20
- 3 min
Forest Hills Lab receives FDA approval to proceed with a Phase 2 clinical trial for Parkinson's
“This is an important milestone for a disorder that remains largely unaddressed. Currently, there is no effective drug treatment for CNS...
- Jul 16
- 3 min
Puma Biotechnology and NCCN collaborate to research gastric and gastroesophageal cancers
he role of neratinib in gastric and gastroesophageal cancers as well as neurofibromatosis 2.
- Jul 1
- 4 min
Kintara Reports Topline Results From Phase 2 Clinical Trial of VAL-083 for Recurrent GBM
"I'm extremely pleased with the outcome of the recurrent arm of the study as it provided important safety and efficacy data to support..."
- Jun 27
- 4 min
Sana Biotechnology presents data showing survival of transplanted hypoimmune stem cells in primates
These findings represent a major breakthrough in cell transplantation, as demonstration of immune evasion and durable cell survival...
- Jun 23
- 2 min
SaNOtize begins enrollment for Phase III trials for its COVID-19 anti-viral treatment
The SaNOtize treatment is based on nitric oxide a natural nanomolecule produced by the human body with proven anti-microbial properties
- Jun 8
- 2 min
Iksuda Therapeutics raises $47 Million to further clinical progression for antibody drug conjugates
Iksuda’s programmes target tumours that currently have limited treatment options and high relapse rates.
- Jun 6
- 4 min
KalVista Pharmaceuticals Presents Phase 2 Clinical Data treatment for hereditary angioedema
“Our goal is to provide the best outcome for hereditary angioedema (HAE) patients experiencing an attack..."
- Jun 5
- 6 min
Puma Biotechnology data: Dose escalation of neratinib for HER2-positive early stage breast cancer
Puma Biotechnology is focused on the development and commercialization of innovative products to enhance cancer care.
- Jun 3
- 4 min
Lixte Biotechnology enrolls first patient in Phase 1b trial for treatment of small cell lung cancer
“Small cell lung cancer comprises approximately 15% of all lung cancers worldwide with about 30,000 new cases annually in the U.S.”